Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab.

Ugo De GiorgiGiuseppe ProcopioDiana GiannarelliRoberto SabbatiniAlessandra BearzSebastiano Buti Umberto BassoManfred MittererCinzia OrtegaPaolo BidoliFrancesco FerraùLucio CrinòAntonio FrassoldatiPaolo MarchettiEnrico MiniAlessandro ScoppolaClaudio VerusioGiuseppe FornariniGiacomo CartenìClaudia CasertaCora N Sternberg

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)

Normal BMI combined with inflammation tripled the risk of death, suggesting that these biomarkers are critical prognostic factors for OS in patients with RCC treated with nivolumab.

Keyphrases

prognostic factors
body mass index
weight gain
papillary thyroid
oxidative stress
single cell
physical activity
cell therapy
newly diagnosed
squamous cell
renal cell carcinoma
stem cells
squamous cell carcinoma
free survival